基于5種草屬藥用植物的5個(gè)分子身份證的構(gòu)建_第1頁(yè)
基于5種草屬藥用植物的5個(gè)分子身份證的構(gòu)建_第2頁(yè)
基于5種草屬藥用植物的5個(gè)分子身份證的構(gòu)建_第3頁(yè)
基于5種草屬藥用植物的5個(gè)分子身份證的構(gòu)建_第4頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

基于5種草屬藥用植物的5個(gè)分子身份證的構(gòu)建

genomica(洋務(wù))的目標(biāo)是近250年的。對(duì)于一般知識(shí),它被認(rèn)為是“西蒙泰”的“非洲”。在這條規(guī)則中,“米卡”是第一學(xué)期的非預(yù)算資源,“米卡”是第二學(xué)期的非預(yù)算資源。這是報(bào)告的。時(shí)間短,主要是短期間。它是一個(gè)緩慢的地方。特征。馬蹄蓮和科茨官人是行動(dòng)的一部分。證據(jù)表明,這些因素是自給自足的。這是一個(gè)非常普遍的做法。就像它一樣,它是一個(gè)緩慢的步驟,而不是一個(gè)受歡迎的替代形式??傊且粋€(gè)受歡迎的例子。Comparedwiththemorphologicalandchemicalmethods,moleculargeneticmethods,especiallythosePCR-basedmethods,havebeenprovedstable,reliableandefficienttoidentifytheherbalmedicines.TheARMS(amplificationrefractorymutationsystem)isalsodescribedasallele-specificPCR,whichcoulddetectsinglebasemutations.Now,ARMShavesuccessfullybeenusedtoauthenticateherbmedicinessuchasPanaxginseng,Alismaorientaleetal.Inhighereukaryotes,the5SrDNAunitconsistsofa120bpconserved5SrRNAgenecodingregionandnon-transcribedspacer(NTS)ofvarioussize.SuchdiversityoftheNTSindifferentspeciescanbeusedasanidentificationbasis.InthisstudyweestablishedthetechniqueofARMSbasedon5SrDNAsequence,toidentifyV.jatamansifromotherValerianaspeciesandherbalmedicinesefficientlyandconvenientlyandascertainthephylogeneticrelationshipamongfiveValerianaspecies.杏仁杏仁1u2004范圍ThefivetestedspeciesdistributinginSouthwestChinaincludedV.jatamansi,V.pseudofficinalisC.Y.ChengetH.B.Chen,V.officinalisLinn.var.latifoliaMiq.,V.hardwickiiWall.andV.flaccidissimaMaxim.AllthespecimenswerecollectedandcultivatedinInstituteofChineseHerbalMedicines,HubeiAcademyofAgriculturalSciences.PlantmaterialswereauthenticatedbyProf.Lin(HubeiAcademyofAgriculturalSciences)andthevoucherswerekeptinWuhanUniversity.Youngleavesweredriedinsilicagelandusedasresearchmaterials.DetailedmessagesofspecimensweredepictedinTable1.Inaddition,fortheherbalmedicinepreparations,threeitemsavailableinthemarketplacewereboughtfromAierkangpharmacy(Wuhan)andusedinARMSanalysis,includingXiangGuoJianXiaoPian(sugarcoatedtablet,producedbyYunnanYunheMedicineCo.,Ltd.,batchnumber:07020602),aresourcecontainingthepowderofroastedRhizomaValerianajatamansi,andRenShenGuiPiWan(honeyedpill,producedbyJilinShuangshiMedicineCo.,Ltd.,batchnumber:080101)andXiaoYaoWan(wateredpill,producedbyChinaResourcesSanjiuMedical&PharmaceuticalCo.,Ltd.,batchnumber:090301),theresourceswithoutRhizomaValerianajatamansi.2pcrpcrThedryleavesandherbalmedicinepreparationsweregroundtofinepowdersinliquidnitrogen.GenomicDNAwasextractedusingtheDNAextractionkit(BeijingTiangenCo.,Ltd).AccordingtoFukuietal.,thecomplete5SrDNANTSregionwereamplifiedbyusingprimersofNF(5’-GATCCCATCAGAACTCCGAAG-3’)andNR(5’-CGGTGATTTAGTGCTGGTAT-3’).Each25μLPCRmixturecontained:50ngoftotalgenomicDNA,400mmol·L-1ofeachdNTP,1UTaqpolymerase(DingguoBiotechnologyCo.Ltd.),1×PCRbuffer,2.0mmol·L-1MgCl2,and0.4mmol·L-1ofeachprimer.Sampleswereamplifiedthrough30thermalcyclesinMJ-PTC100TM(EastwinLifeSciences,Inc.),andeachcycleconsistingof94℃for30sec,55℃for30sec,and72℃for1min.ThePCRproductswereextractedfromgels,clonedintopGEM-Tvector(Promega),andatleastthreeclonesofeachspecimenweresequencedonanABI3730XLsequencer(SunbiotechCo.,Ltd,Beijing,China).AllsequencesweresubmittedtoGenBank.SequenceswerealignedandclusteredusingClustalXandDNAMANVersion4.0software,respectively.3ssrnareieeBasedonthenucleotidesubstitutionsintheNTSofV.jatamansi,sixreversediagnosticprimerswithcomplementary3’-residuesweredesignedforARMSanalysis,separately(Table2).AllthecorrespondingforwardprimerswereNF.ThePCRprocedureofARMSanalysiswasthesameasthePCRamplificationof5SrDNAregionandtheannealingtemperaturewasoptimizedwithintherangeof55-60℃.ThegenomicDNAisolatedfromtheherbaldrugsofXiangGuoJianXiaoPian,RenShenGuiPiWanandXiaoYaoWanweretestedwithARMSanalysisinthesamePCRconditionusingtheselecteddiagnosticprimer.PCRproductswerecheckedona1.2%agarosegelandwerevisualizedbyethidiumbromidestainingunderUV.NegativecontrolswereperformedalongwitheachPCRamplification.ThreeindependentexperimentsforARMSweretestedtoverifythereproducibilityofthemethods.partiace安氏回復(fù)突變armsimasimasoinficiensima,simasima,sima,sima,sima,laciratchening,etizact.u2005.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.3.5.3.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.3.5.3.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5.5ThePCRproductcontainedpartial5SrRNAgeneandcompleteNTSsequences.SizedifferencesofPCRproductswerenotdetectedunderagarosegelelectrophoresis.Accordingtothesequencingresults,different5SrDNAsequencesofeachtestedspecieswereselectedforthefurtherstudies.Thesequenceanalysisofdifferentclonesfoundthatthecodingsequencesof5SrRNAgenewereconserved,buttheNTSsequencevariedinthetestedspecies.TheNTSregionvariedfrom189to225ntinV.jatamansi,212-213ntinV.pseudofficinalis,212-213ntinV.officinalisvar.latifolia,237-244ntinV.hardwickiiand190-233ntinV.flaccidissima.ItseemsthatNTSdivergencewithinonespecieswascomparablystableforV.flaccidissima,V.hardwickiiandV.jatamansiamongthefivetestedspecies.Inthephylogenetictree,NTSsequencesfromV.flaccidissima,V.hardwickiiandV.jatamansiclusteredintoasubclade,separately,whilethoseofV.pseudofficinalisandV.officinalisvar.latifolianestedtogether(Figure1).ThisresultsuggestedV.pseudofficinalisandV.officinalisvar.latifoliahadthecloserelationshipamongthetestedspecies.V.hardwickiishowedthelongestbranchintheclustertreewhichindicatedithadthefarthestgeneticdistancetotheotherfourspecies.ForARMSanalysis,thesamenucleotidesubstitutionsindifferentclonesofV.jatamansiwerefoundatposition171(EU926613),167(EU926614)and174(EU926615),respectively.SixdiagnosticprimersweredesignedforARMSanalysisonthebasisoftheSNPsite.Inordertoensureamplificationspecificity,onestrongdestabilizingmismatch(G/CpairreplacedbyG/Tpair)wasdeliberatelyintroducedintoprimerzhiR5atthe1stnucleotidefrom3’terminus.Thefivespecieswereamplifiedwiththesixspecificprimers,respectively.Theoretically,onlyV.jatamansishouldbesuccessfullyamplified.Expectedly,primerzhiR5couldamplifythefragmentapproximate200bpinV.jatamansiwiththeannealingtemperature58℃andnoPCRproductwasobservedintheotherfourtestedspeciesatthesametime(Figure2a).TherestofdiagnosticprimerscouldnotamplifytheexpectedDNAfragmentinallthePCRamplifications.Therefore,thesefiveprimerscouldnotbeusedforauthenticationofV.jatamansiexceptprimerzhiR5.ThreeherbalmedicinepreparationsfrommarketwereusedtotestthereliabilityofARMSmethodusingprimerpairzhiR5andNF.ThesamplecontainingV.jatamansishowedthepositivefragmentasexpectedafterthePCRamplification,whilenoPCRproductwasfoundintheothertwoherbalmedicinepreparationwhichnotcontainingtheresourceofV.jatamansi(Figure2b).TheseresultssuggestedthisARMSanalysiscouldbeusednotonlytoauthenticatethegenuineplantofV.jatamansifromValerianaspeciesbutalsoidentifyV.jatamansifromtheherbalmedicinepreparations.Inthisstudy,5SrDNAsequenceisprovedtobeausefulspecies-specificmarkerforphylogeneticanalysisofValerianaspecies.ThuswecouldgetdeepinsightoftherelationshipamongthespeciesonDNAlevelbesidesthemorphologicalanalysis.V.pseudofficinaliswasthemostwidelyusedforsedatio

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論